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CASE REPORT
Small Cell Lung Cancer in a 26-Year-Old Man with
Significant Cannabis Exposure
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A 26-year-old man presented with a 3-month history ofchest pain, facial swelling, lumps within his axillae, and
weight loss. Examination confirmed right axillary lymphad-
enopathy and early signs of superior vena caval obstruction.
He had no significant medical or family history. The patient
denied cigarette smoking; however, smoked large quantities
of cannabis. He began smoking cannabis at the age of 14
years, initially one to two joints daily. Between the ages of 18
and 24 years, his cannabis consumption increased to eight
joints daily.
Chest radiograph (Figure 1) showed widening of the
right superior mediastinum. Opacities were seen in right hilar
and right paratracheal regions. Computed tomography (CT)
of the thorax (Figure 2) showed a large anterior mediastinal
mass with right hilar, right paratracheal, and subcarinal
lymphadenopathy. There was a small-volume lymph node in
the right axilla. Multiple pulmonary nodules and two small
liver lesions were identified.
Initial impression was of metastatic teratoma or lym-
phoma. Ultrasound of the testicles was normal. The axillary
node at 1 cm was equivocal; therefore, CT-guided biopsy of
the mediastinal mass was performed. The histology result
was small cell lung cancer (Figure 3).
The patient received chemotherapy with six cycles of
cisplatin and etoposide. After chemotherapy treatment, repeat
CT scan demonstrated an improvement in appearance of
lymph nodes and stable lung nodules. The mediastinal mass
appearance was stable in size but denser in appearance. The
liver nodules had increased in size, and concerns of potential
new bony lesions were raised.
Because of this progression through treatment, further
chemotherapy was proposed. Cyclophosphamide, doxorubi-
cin, vincristine, and etoposide were used in combination in
the CAVE regimen. The patient received five cycles; how-
ever, CT scan demonstrated definite evidence of disease
progression in the anterior mediastinum and liver after this
treatment.
The patient decided to source private treatment after
being informed that there were no further conventional treat-
ments available and that priority would be symptom control.
The patient traveled to Mexico and received weekly carbo-
platin supported by “Focused Anti-Neoplastic Chemother-
apy” for 3 months.
Unfortunately, the disease again progressed through
treatment, and the patient died on return to UK after this
course of chemotherapy in Mexico. Time of survival form
diagnosis was 2 years, 16 days.
Cannabis is the most commonly used illegal drug in
UK,1 usually consumed through smoking, with tobacco, in
unfiltered joints.2 It is unclear whether cannabis can increase
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FIGURE 1. Chest radiograph at initial presentation showing
widening of the superior mediastinum, predominantly on
the right side, with opacities in the right hilar and right
paratracheal regions.
Journal of Thoracic Oncology • Volume 6, Number 1, January 2011218
the risk of developing cancer of the respiratory tract indepen-
dently from tobacco, as reports have produced conflicting
evidence. Recent research suggests that the risk of pulmonary
malignancy could be significantly increased by cannabis use.3
At 26 years, this patient is by far the youngest to be
diagnosed with small cell lung cancer at our institution.
In the West Midlands, there have been 31 cases of lung
cancer reported in patients younger than 30 years over the
past 20 years, only one of which had small cell carcinoma
morphology (3.2%) (West Midlands Cancer Intelligence
Unit, e-mail communication, 24 February 2010).
Data from the National Lung Cancer Audit database
demonstrate that approximately 0.05% of small cell lung
cancer patients in UK have presented at age younger than 30
years. This equates to 5 of the 10,495 patients held in this
dataset (National Lung Cancer Audit Network, e-mail com-
munication, 18 March 2010).
In this case, there was a low total smoking pack-year
exposure and no known genetic predisposition to developing
lung cancer. A recent case–control study from Aldington et
al.3 of young New Zealand residents found that each joint-
year (one joint per day for 1 year) increased the risk of lung
cancer by 8%. Smoking one joint of cannabis per day pro-
duces a similar risk of malignancy as smoking 20 cigarettes
per day.3 With a 20 joint-year cannabis history, equivalent to
a 20 pack-year history,3 it seems likely that this patient’s
cancer developed as a result of cannabis smoking. From a
public health perspective, young people should be aware that
smoking cannabis is likely to be associated with development
of lung cancer, which in the case of our patient led to his early
demise.
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FIGURE 2. Pretreatment computed tomography of the tho-
rax demonstrating a large anterior mediastinal mass.
FIGURE 3. Photomicrograph 400 showing fibrotic tissue
infiltrated by a basophilic small cell infiltrate showing nuclear
molding and focal crush artifact in keeping with small cell
carcinoma. Tumor cells express broad spectrum cytokeratin
and TTF and focal CD56.
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